| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10059134 | HBV | ENSG00000228278.5 | protein_coding | ORM2 | No | No | 5005 | P19652 |
| TVIS10060166 | HBV | ENSG00000228278.5 | protein_coding | ORM2 | No | No | 5005 | P19652 |
| TVIS10059151 | HBV | ENSG00000228278.5 | protein_coding | ORM2 | No | No | 5005 | P19652 |
| TVIS10060221 | HBV | ENSG00000228278.5 | protein_coding | ORM2 | No | No | 5005 | P19652 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ORM2 |
|---|---|
| DrugBank ID | DB00458 |
| Drug Name | Imipramine |
| Target ID | BE0003663 |
| UniProt ID | P19652 |
| Regulation Type | |
| PubMed IDs | 8946472 |
| Citations | Herve F, Duche JC, d'Athis P, Marche C, Barre J, Tillement JP: Binding of disopyramide, methadone, dipyridamole, chlorpromazine, lignocaine and progesterone to the two main genetic variants of human alpha 1-acid glycoprotein: evidence for drug-binding differences between the variants and for the presence of two separate drug-binding sites on alpha 1-acid glycoprotein. Pharmacogenetics. 1996 Oct;6(5):403-15. |
| Groups | Approved |
| Direct Classification | Dibenzazepines |
| SMILES | CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12 |
| Pathways | Imipramine Metabolism Pathway; Imipramine Action Pathway |
| PharmGKB | PA449969 |
| ChEMBL | CHEMBL11 |
